Related Experiment Video
Updated: Jun 19, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Infective endocarditis in the grown-up congenital heart (GUCH) population
1Grown-up Congenital Heart Unit, Royal Brompton Hospital, London, U.K.
Insights
Infective endocarditis in adults with congenital heart disease is linked to specific lesions, with delayed diagnosis increasing mortality. Prophylaxis may not be necessary for all congenital heart anomalies.
Area of Science:
- Cardiology
- Infectious Diseases
- Congenital Heart Disease
Background:
- Infective endocarditis (IE) is a significant concern in adults with congenital heart disease (ACHD), accounting for 4% of admissions to specialized units.
- Identifying lesions susceptible to IE, predisposing events, and outcomes is crucial for managing this patient population.
Purpose of the Study:
- To define lesions susceptible to infective endocarditis in adults with congenital heart disease.
- To identify antecedent events, causative organisms, and outcomes in this patient group.
- To evaluate the role and effectiveness of surgical treatment for infective endocarditis in ACHD patients.
Main Methods:
- Retrospective analysis of the grown-up congenital heart disease database from 1983-1996.
- Inclusion of 185 patients (214 episodes) divided into unoperated/palliated (Group I) and post-definitive repair (Group II) groups.
- Detailed review of affected cardiac sites, predisposing events, microbial organisms, diagnostic timelines, and surgical interventions.
Main Results:
- Commonly affected sites included ventricular septal defects, left ventricular outflow tracts, and mitral valves, varying between unoperated and post-repair groups.
- Predisposing events were identified in 41% of patients, with dental procedures/sepsis in Group I and cardiac surgery in Group II.
- Streptococci and Staphylococci species were the predominant organisms; mean diagnosis time was longer in Group I (60 days) vs. Group II (29 days).
- Overall mortality was 4%, primarily linked to Staphylococcus aureus infection and complications from emergency/repeated surgery. Recurrent IE occurred in 11% of patients.
Conclusions:
- Reparative surgery for congenital heart disease does not universally prevent infective endocarditis, with exceptions for ventricular septal defect and duct closure.
- Delayed diagnosis significantly contributes to mortality, highlighting the need for prompt recognition and treatment.
- Certain congenital heart anomalies may not require endocarditis prophylaxis due to a low risk of infection.
Aims:
Infective endocarditis accounts for 4% of admissions to a specialized unit for grown-up congenital heart patients. This study defines lesions susceptible to infection, antecedent events, organisms, outcome and surgical treatment in a group of such patients.
Methods And Results:
The grown-up congenital heart disease database was searched for all patients aged 13 years and above with adequate documentation of infective endocarditis retrospectively between 1983-1993 and thereafter between 1993-1996. There were 185 patients (214 episodes) divided into Group I: 128 patients unoperated or palliated and Group II: 57 patients after definitive repair and/or valve repair/replacement. In Group I, the commonest affected sites were ventricular septal defect in 31 (24%), left ventricular outflow tract in 22 (17%) and mitral valve in 17 (13%) and in Group II, left ventricular outflow tract in 20 (35%), repaired Fallot in 11 (19%), and atrioventricular defects in eight (14%). Infective endocarditis was not seen in secundum atrial septal defects before or after closure; in closed ventricular septal defects and ducts without left-sided valve abnormality; in isolated pulmonary stenosis; in unrepaired Ebstein: or after Fontan-type or Mustard operations. Surgery was performed in 39 patients: as an emergency in 17, and for failed medical therapy in 22. Only 87 (41%) of patients had a predisposing event: dental procedure or sepsis were the commonest events in Group I (33%) and cardiac surgery in Group II (50%). Streptococci species were found in 54% of Group I patients and in 45% of Group II. Staphylococci aureus was commoner in Group II (25%) compared to Group I (14%). Mean time from the onset of symptoms to diagnosis was 60 and 29 days in Groups I and II, respectively. Eight (4%) patients died as a result of septicaemia related to emergency or repeated surgery and Staphylococcus aureus infection. Recurrent attacks occurred in 21 (11%) patients.
Conclusion:
Reparative surgery does not prevent endocarditis except for closure of a ventricular septal defect and duct. Delay in diagnosis is serious since it contributes to mortality, although the overall mortality % is not high. Specific lesions are not affected so prophylaxis is probably unnecessary in those anomalies.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction

